Guangzhou, China

Yehua Jin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Launch-Pharma Technologies, Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yehua Jin. Retrieved from https://idiyas.com/inventor/yehua-jin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yehua Jin - Innovator in Pharmaceutical Synthesis

Introduction

Yehua Jin is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for producing important medicinal compounds.

Latest Patents

Yehua Jin holds a patent for an entecavir intermediate and its synthetic method. The patent, titled "Entecavir intermediate, synthetic method thereof and synthetic method for entecavir," describes a novel approach to synthesizing entecavir. This method is notable for its controllable chirality, high yield, and product purity. Additionally, it utilizes readily available and inexpensive raw materials, making it an environmentally friendly option suitable for industrial-scale production.

Career Highlights

Yehua Jin is currently associated with Launch-Pharma Technologies, Ltd., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its practical applications and efficiency in drug synthesis.

Collaborations

Yehua collaborates with talented professionals in his field, including Fang Wang and Fayang Qiu. Their combined expertise contributes to the advancement of pharmaceutical technologies.

Conclusion

Yehua Jin's innovative work in synthetic methods for pharmaceuticals exemplifies the impact of inventors in advancing medical science. His contributions are paving the way for more efficient and sustainable drug production methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…